Researchers presented a cross-sectional comparative analysis among three groups that included antibodies to citrullinated protein antigens (ACPA) positive individuals without inflammatory arthritis, ACPA negative individuals, and individuals with early, ACPA positive clinical rheumatoid arthritis.
[Nature Communications]